HomeCNTA • NASDAQ
add
Centessa Pharmaceuticals PLC - ADR
Previous close
$16.10
Day range
$15.27 - $15.98
Year range
$6.65 - $18.97
Market cap
2.06B USD
Avg Volume
611.63K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 46.40M | 15.41% |
Net income | -42.57M | -10.14% |
Net profit margin | — | — |
Earnings per share | -0.37 | 7.50% |
EBITDA | -46.32M | -15.45% |
Effective tax rate | -1.45% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 518.45M | 84.28% |
Total assets | 609.72M | 61.57% |
Total liabilities | 110.58M | -6.27% |
Total equity | 499.14M | — |
Shares outstanding | 131.85M | — |
Price to book | 4.25 | — |
Return on assets | -23.01% | — |
Return on capital | -24.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -42.57M | -10.14% |
Cash from operations | -21.39M | 42.80% |
Cash from investing | 44.96M | -7.68% |
Cash from financing | 245.98M | 1,568.36% |
Net change in cash | 267.65M | 918.55% |
Free cash flow | -11.57M | 47.87% |
About
Founded
2020
Website
Employees
75
